Citigroup Inc Abcam PLC Transaction History

Citigroup Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$21.54 - $24.41 $4.98 Million - $5.65 Million	231,334 Added 2730.25%	239,807 $5.43 Million
Q2 2023 Aug 10, 2023	SELL	$12.62 - $24.47 $29.2 Million - $56.7 Million	-2,317,595 Reduced 99.64%	8,473 $207,000
Q1 2023 May 11, 2023	BUY	$12.98 - $17.1 $29.8 Million - $39.2 Million	2,294,133 Added 7183.76%	2,326,068 $31.3 Million
Q4 2022 Feb 09, 2023	BUY	$13.92 - $17.0 $348,013 - $425,017	25,001 Added 360.56%	31,935 $496,000
Q3 2022 Nov 10, 2022	SELL	$13.36 - $16.75 $2,498 - $3,132	-187 Reduced 2.63%	6,934 $104,000
Q2 2022 Aug 10, 2022	SELL	$12.69 - $19.25 $100,492 - $152,440	-7,919 Reduced 52.65%	7,121 $103,000
Q1 2022 May 12, 2022	SELL	$15.5 - $23.89 $44,144 - $68,038	-2,848 Reduced 15.92%	15,040 $275,000
Q4 2021 Feb 10, 2022	SELL	$20.04 - $23.84 $274,968 - $327,108	-13,721 Reduced 43.41%	17,888 $421,000
Q3 2021 Nov 10, 2021	BUY	$17.38 - $21.54 $549,364 - $680,857	31,609 New	31,609 $641,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.